NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

腫瘤資訊系統的全球市場 (2021年∼2028年)

Global Oncology Information Systems Market - 2021-2028

出版商 DataM Intelligence 商品編碼 1008537
出版日期 內容資訊 英文 180 Pages
商品交期: 約2個工作天內
價格
腫瘤資訊系統的全球市場 (2021年∼2028年) Global Oncology Information Systems Market - 2021-2028
出版日期: 2021年06月01日內容資訊: 英文 180 Pages
簡介

全球腫瘤信息系統(OIS)市場的主要驅動力是癌症病例的增加、政府癌症意識努力的結果、管道產品的增加以及比傳統人工處理更高效的IT服務需求增加。按應用,放射腫瘤學的需求佔據了大部分市場。按地區劃分,北美預計將成為最大的市場,而亞太地區預計也將經歷顯著的市場增長。

本報告提供全球腫瘤資訊系統的市場相關分析,提供市場規模趨勢預測,及產品/各類服務·各用途·各終端用戶·各地區的詳細趨勢,主要的推動及阻礙市場要素,主要企業的簡介等相關調查。

目錄

第1章 全球腫瘤資訊系統市場:分析方法·範圍

第2章 全球腫瘤資訊系統市場:市場定義和概要

第3章 全球腫瘤資訊系統市場:摘要整理

第4章 全球腫瘤資訊系統市場:市場動態

  • 對市場的影響要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 全球腫瘤資訊系統市場:產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 法規分析
  • 償付分析
  • 未滿足需求

第6章 全球腫瘤資訊系統市場:新型冠狀病毒感染疾病 (COVID-19)的分析

  • COVID-19對市場的影響分析
    • COVID-19前的市場方案
    • 目前市場方案
    • COVID-19後的市場方案
  • COVID-19疫情下的價格趨勢
  • 需求與供給的變動階段
  • 政府在COVID-19疫情下的市場相關措施
  • 各製造公司的策略展開情形
  • 結論

第7章 全球腫瘤資訊系統市場:產品·各類服務

  • 簡介
    • 市場規模的分析與與前一年同期相比成長率 (YoY):產品·各類服務
    • 市場向心力指數:產品·各類服務
  • 軟體
    • 患者資訊系統
      • 簡介
      • 市場規模 (以金額為準,2018年∼2028年)·與前一年同期相比成長率 (YoY) (2020年∼2028年)
    • 治療計劃系統
    • 治療管理系統·醫療影像分析系統
  • 服務
    • 諮詢/最佳化服務
    • 實行服務
    • 售後服務·整備服務

第8章 全球腫瘤資訊系統市場:各用途

  • 簡介
    • 市場規模的分析與與前一年同期相比成長率 (YoY):各用途
    • 市場向心力指數:各用途
  • 放射線腫瘤學
  • 腫瘤內科
  • 外科腫瘤學

第9章 全球腫瘤資訊系統市場:各終端用戶

  • 簡介
    • 市場規模的分析與與前一年同期相比成長率 (YoY):各終端用戶
    • 市場向心力指數:各終端用戶
  • 醫院·影像診斷中心
  • 政府機關
  • 門診病人手術中心
  • 研究設施

第10章 全球腫瘤資訊系統市場:各地區

  • 簡介
    • 市場規模和與前一年同期相比成長率 (YoY):各地區
    • 市場向心力指數:各地區
  • 北美
    • 簡介
    • 域內市場固有趨勢
    • 市場規模·與前一年同期相比成長率 (YoY):產品·各類服務
    • 市場規模·與前一年同期相比成長率 (YoY):各用途
    • 市場規模·與前一年同期相比成長率 (YoY):各終端用戶
    • 市場規模·與前一年同期相比成長率 (YoY):各國
  • 歐洲
  • 南美
  • 亞太地區
  • 中東·非洲

第11章 全球腫瘤資訊系統市場:競爭情形

  • 主要趨勢與策略
  • 企業佔有率分析
  • 產品的互相比較

第12章 全球腫瘤資訊系統市場:企業簡介

  • Koninklijke Philips N.V.
    • 企業概要
    • 產品的組合/概要
    • 近幾年趨勢
    • 財務分析:概要
  • Varian Medical Systems Bayer
  • McKesson Corporation
  • Siemens Healthineers
  • Elekta AB
  • Epic Systems Corporation
  • IBM
  • Cerner Corporation
  • Advanced Data Systems
  • Bogardus Medical Systems, Inc

第13章 關於DataM Intelligence

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Market Overview

The global oncology information systems market size was valued US$ XX billion in 2019 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

Oncology information systems (OIS) are used to manage the data of cancer patient hospitalization programs, treatment deliveries, treatment plans, and diagnostic results. The OIS will enclose the information transfer with different departments inside the health care enterprise, and it must be connected to different hospitals' information systems. It will support the evaluation and improvement of treatment from information on cancer stage and treatment. OIS accredits increased medical safety and professional effectiveness. Several resources like paper-based (hospital registries), network, and others will help maintain oncology information at healthcare enterprise.

Market Dynamics

The oncology information systems market growth is driven by the increasing demand for IT services due to increasing prevalence of cancer cases is expected to fuel the growth of the oncology information systems market. It is advantageous over traditional data handling & validations, and it further decreased the manual effort and automated the process. The oncology information system has immense applicability in healthcare settings for better management of cancer patients.

The rising incidence of cancer worldwide will drive the market growth

The significant factors associating with the growth of the OIS market include the increasing incidence of cancer cases worldwide. A rise in the geriatric population also drives the demand for oncology information systems and drives market growth.

As per the Globocan 2020 fact sheet, an expected 19,292,789 new cancer cases were diagnosed worldwide, with approximately 9,958,133 deaths due to cancers globally. Additionally, according to estimates of the International Agency for Research on Cancer, by 2040, the global burden of cancers is anticipated to grow to 27.5 million new cancer cases and 16.3 million deaths worldwide.

Owing to the growing number of specific treatments in the oncology pipeline, the number of late-stage pipeline treatments rose from 711 in 2017 to 849 in 2018, an increase of 19% and the use of information systems help in maintaining the data of these treatments between the healthcare organization and treatment providers/patients are boosting the market growth.

Growing government initiatives for cancer awareness is driving the market growth

Governments worldwide are proposing reforms and introducing new regulations that would assist in the enterprise-wide and general adoption of information technologies, including OIS, which aid in the transmutation of healthcare systems. For instance, in the United States, the Health Information Technology for Economic and Clinical Health (HITECH) Act enacted under the American Recovery and Reinvestment Act allocated funding to incentivize hospital physicians to confirm meaningful use of EHRs. The availability of superior Healthcare IT solutions for cancer care generates significant interest among end-users due to the better treatment outcomes promised by them.

High cost of oncology information systems will hamper the market growth

The cost of OIS for various medical devices is considerably high. Affordability is an essential provocation for healthcare organizations, particularly in emerging countries, where it is challenging to obtain budgetary permissions for IT solutions over medical equipment. Smaller healthcare organizations strive to implement Internet connectivity to medical devices, primarily due to difficulties in executing various networks with health settings, wireless connectivity alternatives, and installing security layers to withdraw data breaches. In addition, the infrastructural expenses for performing an oncology information system and connecting it with different devices with different interfaces form a vital obstacle to market growth in emerging countries. The implementation and subscription fees for integration solutions are the vital financial burden and add to the budgetary woes faced by many hospitals.

COVID-19 Impact Analysis

Due to the pandemic, the access to customers to sell and implement the OIS reduced as hospitals became primarily focused on the COVID-19 patients. The pandemic has led to a significant reduction in the requirement for OIS. The pandemic has also influenced the oncology field since doctors cannot focus on regular patients since they are being redeployed for treating COVID-19 patients. Therefore, performing oncology surgery and treatment has become a significant challenge with the non-availability of hospital staff and operation facilities. Moreover, the market for OIS is expecting to recover the losses when the situation becomes normal.

Segment Analysis

By product & services, the oncology information systems market is classified into software ( patient information systems, treatment planning systems, reatment management systems & medical, image analysis systems), services (consulting/optimization services, implementation services, post-sale and maintenance services)

Software segment is expected to grow at the fastest CAGR during the forecast period (2021-2028)

The software segment has dominated the market due to the increase in cancer patients globally and the tests associated with examining and treating cancer patients. According to GLOBOCAN 2018, there is an estimated 2,129,118 incident cases in the United States in 2018, which is expected to grow by 2040 and reach 3,096,944 cases. As the number of people with cancer increases, keeping track of patient data and coordinating treatment plans is challenging for doctors and medical professionals. Softwares of oncology information systems can help medical professionals track all the information related to patient and their treatment. The oncology information system software helps physicians to improve the management of patient information.

The patient information systems segment has the largest share in the software segment. A patient information system is a kind of clinical information system assigned to collecting, storing, manipulating, and making available clinical information crucial to the delivery of patient care. The primary focus of such systems is clinical data and not financial or billing data.

It also involves those systems that handle data related to the activities of providers and health organizations. As an integrated effort, these may be leveraged to improve patient outcomes, inform research, and influence policy-making and decision-making. Because health information systems commonly access, process, or maintain large volumes of sensitive data, security is a primary concern.

On the basis of application, the the oncology information systems market is classified into radiation oncology, medical oncology, surgical oncology.

The radiation oncology segment are expected to dominate the oncology information systems market during the forecast period

The radiation oncology segment expected a larger share of the market. The growing installation base for radiotherapy devices, the growing number of radiosurgery systems related to fractures, rapid growth in cancer-affected populations across the globe, and the expansion of advanced radiology information systems and radiation treatment planning systems are constituents expected to propel the growth of this market. For instance, according to the Organisation for Economic Co-operation and Development, in the U.S., the number of radiation oncology equipment increased from 11.5 in 2018 to 11.7 per 1000,000 inhabitants in 2019. These factors are driving the segment growth in the forecast period.

It is estimated that 145,483 Australians were diagnosed with cancer in 2020. The age-standardized percentage rate in 2020 is estimated to be 480 cases per 100,000 persons. In 2017, 24,453 cancers were recorded in New Zealand, at an age-standardized percentage rate of 331 per 100,000 people. It is estimated that about half of cancer patients will avail of radiation treatment due to their overall cancer therapy. Also, 1 in 2 patients with cancer may benefit from radiation oncology treatment at some point during their illness.

Radiation oncology treatment is a highly cost-effective cancer treatment. It requires less than 9 cents out of each healthcare dollar spent on treating cancer overall, yet it is essential in about 40% of all cured cancers. With cancer being the leading case of death worldwide, investment in developing radiation oncology treatments, helping cancer patients access radiation therapy and building new treatment centers have never been more critical.

Geographical Analysis

North America region holds the largest market share in the global Oncology Information Systems market

North America region is dominating the global oncology information systems market accounted for the largest market share in 2020, owing to the such as the rising prevalence of cancer and the availability of advanced healthcare infrastructure.

According to the American Society of Clinical Oncology estimates, there were around 42,220 adults diagnosed with liver cancer in the United States in 2018 (of which there are 30,610 men and 11,610 women). In addition, in 2020, there were around 42,810 new liver cancer cases in the United States 2020. With the increasing cases of cancer in the United States, it is expected to raise demand for oncology information systems to manage the disease.

The increasing R&D to develop patient-centric oncology information systems, rising prevalence of cancer, technological advancements in oncology information systems products and procedures are the key factors supporting market growth in North America. Most of the prominent companies in the global market are headquartered in the region or have a strong presence in this market.

On the other hand, Asia-Pacific is expected to exhibit the fastest growth rate over the forecast period due to the increase in healthcare expenditure, rising awareness about early diagnosis, high unmet clinical needs of patients, and effective treatment in emerging countries, such as China and India.

Competitive Landscape

The oncology information systems market is moderately competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Koninklijke Philips N.V., Varian Medical Systems Bayer, McKesson Corporation, Siemens Healthineers, Elekta AB, Epic Systems Corporation, IBM, Cerner Corporation, Advanced Data Systems, Bogardus Medical Systems, Inc, among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the oncology information systems market globally.

Siemens Healthineers

Overview: Siemens Healthineers is a Germany-based company that provides technology to the healthcare sector companies. The Company has a wide range of products and services in laboratory and point of care diagnostics, diagnostic and therapeutic imaging and molecular medicine. It supplies medical technology and software solutions and clinical consulting services. Additionally, the Company is expanding its digital health and business services through increasing precision medicine, transforming care delivery, improving patient experience, and digitalizing healthcare to enable healthcare providers to increase value.

Product Portfolio: The Company's portfolio comprised of medical imaging, laboratory diagnostics, point-of-care testing, and Healthcare IT, accessories and equipment's, and other areas.

Key Developments: In September 2020, Siemens Healthineers entered into a definitive agreement to acquire Varian Medical Systems. This acquisition will strengthen the company's existing portfolio of oncology information systems

Why Purchase the Report?

  • Visualize the composition of the oncology information systems market segmentation by product & services, application, and end user highlighting the key commercial assets and players.
  • Identify commercial opportunities in oncology information systems market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of oncology information systems market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global oncology information systems market report would provide an access to an approx. 61 market data table, 51 figures and 200 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Table of Contents

1. Global Oncology Information Systems Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Oncology Information Systems Market - Market Definition and Overview

3. Global Oncology Information Systems Market - Executive Summary

  • 3.1. Market Snippet by Product & Services
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by End User
  • 3.4. Market Snippet by Region

4. Global Oncology Information Systems Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising incidence of cancer worldwide will drive the market growth
      • 4.1.1.2. Growing government initiatives for cancer awareness
    • 4.1.2. Restraints:
      • 4.1.2.1. High cost of cancer therapies will hamper market growth
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Oncology Information Systems Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Unmet Needs

6. Global Oncology Information Systems Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Oncology Information Systems Market - By Product & Services

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services Segment
    • 7.1.2. Market Attractiveness Index, By Product & Services Segment
  • 7.2. Software
    • 7.2.1. Patient Information Systems*
      • 7.2.1.1. Introduction
      • 7.2.1.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
    • 7.2.2. Treatment Planning Systems
    • 7.2.3. Treatment Management Systems & Medical Image Analysis Systems
  • 7.3. Services
      • 7.3.1.1. Consulting/Optimization Services
      • 7.3.1.2. Implementation Services
      • 7.3.1.3. Post-Sale and Maintenance Services

8. Global Oncology Information Systems Market - By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Radiation Oncology *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Medical Oncology
  • 8.4. Surgical Oncology

9. Global Oncology Information Systems Market - By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
    • 9.1.2. Market Attractiveness Index, By End User Segment
  • 9.2. Hospitals & Diagnostic Imaging Centers *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 9.3. Government Institutions
  • 9.4. Ambulatory Surgical Centers
  • 9.5. Research Facilities

10. Global Oncology Information Systems Market - By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Global Oncology Information Systems Market - Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking

12. Global Oncology Information Systems Market- Company Profiles

  • 12.1. Koninklijke Philips N.V. *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Varian Medical Systems Bayer
  • 12.3. McKesson Corporation
  • 12.4. Siemens Healthineers
  • 12.5. Elekta AB
  • 12.6. Epic Systems Corporation
  • 12.7. IBM
  • 12.8. Cerner Corporation
  • 12.9. Advanced Data Systems
  • 12.10. Bogardus Medical Systems, Inc

LIST NOT EXHAUSTIVE

13. Global Oncology Information Systems Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us